Device Trial Radar · NCT03873714
Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)
Last checked: Nov 20, 2026Latest source record: Jun 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
14
Actual
Start
Apr 2, 2020
Primary completion
Jul 22, 2021
Study completion Sep 18, 2023
Sponsor
- Lead sponsor
- Medtronic Neurovascular Clinical AffairsPublic (MDT)
- Sponsor type
- Industry
- First posted
- Mar 13, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and effectiveness of the Pipeline™ Vantage Embolization Device with Shield Technology™ in the treatment of intracranial aneurysms within the intended indication for use.
Conditions
- Intracranial Aneurysm
Interventions
Pipeline™ Vantage Embolization Device with Shield Technology™Device
Pipeline™ Vantage Embolization Device with Shield Technology™
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety: Incidence of Major Stroke or Neurological DeathTime frame: 1 year post-procedure
- Effectiveness: Incidence of Complete Aneurysm OcclusionTime frame: 1 year post-procedure
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Baptist Medical Center Jacksonville
Jacksonville, Florida
Jackson Memorial Hospital
Miami, Florida
Stony Brook University Hospital
Stony Brook, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.